Tower Research Capital (TRC)’s Vascular Solutions Inc VASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-149
| Closed | -$8K | – | 4571 |
|
|
2016
Q4 | $8K | Buy |
+149
| New | +$7.59K | ﹤0.01% | 2820 |
|
|
2016
Q3 | – | Sell |
-1,024
| Closed | -$42K | – | 5136 |
|
|
2016
Q2 | $42K | Buy |
1,024
+585
| +133% | +$21.8K | ﹤0.01% | 1694 |
|
|
2016
Q1 | $14K | Buy |
439
+100
| +29% | +$2.88K | ﹤0.01% | 1671 |
|
|
2015
Q4 | $12K | Buy |
+339
| New | +$11.5K | ﹤0.01% | 1958 |
|
|
2015
Q3 | – | Sell |
-2,391
| Closed | -$83K | – | 5334 |
|
|
2015
Q2 | $83K | Buy |
2,391
+1,577
| +194% | +$51.4K | 0.01% | 994 |
|
|
2015
Q1 | $25K | Sell |
814
-292
| -26% | -$8.38K | ﹤0.01% | 2089 |
|
|
2014
Q4 | $30K | Sell |
1,106
-1,006
| -48% | -$27.3K | ﹤0.01% | 1342 |
|
|
2014
Q3 | $52K | Buy |
2,112
+2,023
| +2,273% | +$48K | 0.01% | 1507 |
|
|
2014
Q2 | $2K | Sell |
89
-1,424
| -94% | -$31.2K | ﹤0.01% | 3543 |
|
|
2014
Q1 | $40K | Buy |
+1,513
| New | +$37.7K | 0.01% | 1267 |
|
|
2013
Q4 | – | Sell |
-301
| Closed | -$5K | – | 5227 |
|
|
2013
Q3 | $5K | Buy |
301
+190
| +171% | +$3.08K | ﹤0.01% | 3715 |
|
|
2013
Q2 | $2K | Buy |
+111
| New | +$1.75K | ﹤0.01% | 3575 |
|
Other funds holding VASC
Tower Research Capital (TRC)'s VASC Position: Q1 2017 in Review
Tower Research Capital (TRC) sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 149 shares — an estimated $8K sold.
Tower Research Capital (TRC) first reported a position in VASC in Q2 2013 and held it in 12 quarters. The position peaked at $83K in Q2 2015. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.
- Tower Research Capital (TRC) reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
- Tower Research Capital (TRC) sold 149 Vascular Solutions Inc shares in Q1 2017, an estimated $8K.
- Tower Research Capital (TRC) first reported a position in Vascular Solutions Inc in Q2 2013 and held it in 12 quarters.
- Tower Research Capital (TRC)'s Vascular Solutions Inc position peaked at $83K in Q2 2015.
- 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2017, filed 19 May 2017.